Literature DB >> 2679620

Protein kinase C--a novel target for rational anti-cancer drug design?

A Gescher1, I L Dale.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2679620

Source DB:  PubMed          Journal:  Anticancer Drug Des        ISSN: 0266-9536


× No keyword cloud information.
  7 in total

1.  Isolation and characterization of a novel zinc finger gene, ZNFD, activating AP1(PMA) transcriptional activities.

Authors:  Chen Lei; Qingmei Liu; Weiping Wang; Jun Li; Fengqin Xu; Yuanze Liu; Jiajia Liu; Shiliang Wu; Minghua Wang
Journal:  Mol Cell Biochem       Date:  2010-02-18       Impact factor: 3.396

Review 2.  Cell-signaling targets for antitumour drug development.

Authors:  V G Brunton; P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 3.  Protein kinase C targeting in antineoplastic treatment strategies.

Authors:  W D Jarvis; S Grant
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

Review 4.  Cancer chemotherapy: identifying novel anticancer drugs.

Authors:  J Carmichael
Journal:  BMJ       Date:  1994-05-14

5.  A phase I trial of daily oral 4'- N -benzoyl-staurosporine in combination with protracted continuous infusion 5-fluorouracil in patients with advanced solid malignancies.

Authors:  Joseph P Eder; Rocio Garcia-Carbonero; Jeffrey W Clark; Jeffrey G Supko; Thomas A Puchalski; David P Ryan; Pamela Deluca; Antoinette Wozniak; Angela Campbell; John Rothermel; Patricia LoRusso
Journal:  Invest New Drugs       Date:  2004-04       Impact factor: 3.850

6.  Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides.

Authors:  N M Dean; R McKay
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

7.  In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434.

Authors:  V G Brunton; P Workman
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.